Meet our new faculty members: Prof. Eun Seon Cho and Prof. Yoosik Kim
Introducing new faculty members of KAIST CBE

Prof. Eun Seon Cho

In February 2017, the KAIST CBE Department has received a new faculty member Prof. Eun Seon Cho. Prof. Cho did her B.S. and M.S. at Seoul National University and received a Ph.D. from MIT. She is interested in the design and synthesis of functional hybrid nanomaterials for application in the field of energy and environment. In a recent paper published in Nature Communications last year, Prof. Cho and her colleagues developed a new material for a battery-like hydrogen fuel cell that can store exceptionally dense hydrogen gas, using Mg nanocrystals encapsulated by atomically thin and gas- selective reduced graphene oxide layers. This system prevents the unwanted degradation of Mg crystals due to selective filtering by the graphene layer. This means that the safety concern about hydrogen gas storage can be resolved while simultaneously achieving the reduction in overall storage tank size with faster fueling.

Prof. Yoosik Kim

In January 2016, the KAIST CBE Department has received a new faculty member Prof. Yoosik Kim. Prof. Kim has majored in chemical engineering during his B.E. degree at Dartmouth College. He has received M.A., and Ph.D. degrees from Princeton University analyzing signal transduction pathway during embryo development. Before joining KAIST, Prof. Kim worked as a postdoctoral fellow at Seoul National University where he investigated the function of innate immune response protein during mammalian cell cycle and established double-stranded RNAs as a new class of signaling molecules in human cells.

At KAIST, Prof. Kim´s research applies engineering/biophysical principles to develop models that will provide both molecular and systems-level understanding of biological systems. In particular, his research focuses on identifying and analyzing signaling properties of novel type of RNAs, using quantitative imaging to develop tools for cancer diagnosis, and establishing RNAs as a new class of biomarkers for human degenerative disease.